CBD

Research: CBD Treatment for Cannabis Users with Psychosis, Schizophrenia Bulletin (2018.44.1)

A major factor associated with poor prognostic outcome after a first psychotic break is cannabis misuse, which is prevalent in schizophrenia and particularly common in individuals with recent-onset psychosis. Behavioral interventions aimed at reducing cannabis use have been unsuccessful in this population. New research published in the Schizophrenia Bulletin, suggests that CBD may improve the disease trajectory of individuals with early psychosis and comorbid cannabis misuse in particular—a population with currently poor prognostic outcome and no specialized effective intervention. Read more.